Search - tctmd.com

Displaying 541 - 560 of 1075

Sort: Relevancy | Date

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

L.A. McKeown

October 09, 2019

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Todd Neale

October 04, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

Presentation TCT 2019

Vascular Complications: How to Manage?

Presenter: Camille Brasselet

September 28, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

Presentation TCT 2019

Extreme Aortic Valve Complex Calcification Creating High Risk for TAVR Complications (Rupture or PVR): Case Presentation and Procedural Decision-Making

Presenter: Chiu Wong

September 27, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

News Conference News TCT 2019

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Yael L. Maxwell

September 27, 2019

News Conference News TCT 2019

Learning Curve Exists for MitraClip, Volume-Outcomes Data Hint

Todd Neale

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

Presentation TCT 2019

My Repair Techniques/MitraClip Complications and How to Avoid Them With Case EGS

Presenter: Michael Rinaldi

September 27, 2019

Presentation TCT 2019

TAVR With High Risk for Coronary Obstruction (Low Coronaries and Effaced Sinuses): Case Presentation and Management Strategies — How to Protect the Coronaries, BASILICA, etc.

Presenter: John Forrest

September 26, 2019

Presentation TCT 2019

Severe Symptomatic AS and Moderate/Severe MR: Case Presentation and Management Strategies

Presenter: Anita Asgar

September 26, 2019

Presentation TCT 2019

TAVR in Low-Flow Low-Gradient AS: Case Presentation(s), Diagnostic Algorithms, and Management Strategies

Presenter: Howard Herrmann

September 26, 2019

Presentation TCT 2019

TAVR With Concomitant Complex Coronary Disease: Case Presentation and Management Strategies (Chronic CAD vs ACS Syndromes)

Presenter: David Hildick-Smith

September 26, 2019

Presentation TCT 2019

TAVR in a Small Aortic Annulus: Case Presentation and Management Strategies

Presenter: Itshac Itsik Ben-dor

September 26, 2019

Presentation TCT 2019

TAVR Bioprosthetic Valve Failure (REDO TAVR): Frequency and Management (Including TAV-in-TAV)

Presenter: Uri Landes

September 26, 2019

Presentation TCT 2019

The Growing Concern of Coronary Access After TAVR: Procedural Problem-Solving and Impact on TAVR Device Choices

Presenter: James Hermiller

September 26, 2019

Presentation TCT 2019

Valve Leaflet Thickening and Thrombosis: Definitions, Frequency, Management, and Clinical Importance

Presenter: Lars Sondergaard

September 26, 2019

Presentation TCT 2019

Is Paravalvular Regurgitation Still a Worrisome Complication With New-Generation TAVR Systems?

Presenter: Philippe Pibarot

September 26, 2019

Advertisement

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Vascular Complications: How to Manage?

Portico Noninferior to Commercial TAVR Valves in IDE Study

Extreme Aortic Valve Complex Calcification Creating High Risk for TAVR Complications (Rupture or PVR): Case Presentation and Procedural Decision-Making

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Learning Curve Exists for MitraClip, Volume-Outcomes Data Hint

TCT 2019 Day Two: Transcatheter Valves, New and Old

My Repair Techniques/MitraClip Complications and How to Avoid Them With Case EGS

TAVR With High Risk for Coronary Obstruction (Low Coronaries and Effaced Sinuses): Case Presentation and Management Strategies — How to Protect the Coronaries, BASILICA, etc.

Severe Symptomatic AS and Moderate/Severe MR: Case Presentation and Management Strategies

TAVR in Low-Flow Low-Gradient AS: Case Presentation(s), Diagnostic Algorithms, and Management Strategies

TAVR With Concomitant Complex Coronary Disease: Case Presentation and Management Strategies (Chronic CAD vs ACS Syndromes)

TAVR in a Small Aortic Annulus: Case Presentation and Management Strategies

TAVR Bioprosthetic Valve Failure (REDO TAVR): Frequency and Management (Including TAV-in-TAV)

The Growing Concern of Coronary Access After TAVR: Procedural Problem-Solving and Impact on TAVR Device Choices

Valve Leaflet Thickening and Thrombosis: Definitions, Frequency, Management, and Clinical Importance

Is Paravalvular Regurgitation Still a Worrisome Complication With New-Generation TAVR Systems?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content